Astrazeneca Pharma India Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2011 has recommended a dividend of Rs 10/- per Equity Share of a face value of Rs 2/- each for the Financial Year (15 months period) ended March 31, 2011, subject to the approval of the shareholders at the ensuing Annual General Meeting.Source : BSE
Read all announcements in AstraZeneca
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!